Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | NPFFR1 | Q9GZQ6 | 6/20 | 0.47 |
| ▸ | NPFFR2 | Q9Y5X5 | 6/20 | 0.47 |
| ▸ | DRD2 | P14416 | 4/20 | 0.41 |
| ▸ | DRD4 | P21917 | 4/20 | 0.41 |
| ▸ | DRD3 | P35462 | 4/20 | 0.41 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6170476 | 1.00 | KMT2A (0.48) | KMT2AL3MBTL1NPFFR1NPFFR2DRD2 | |
| SCHEMBL6170470 | 1.00 | KMT2A (0.48) | KMT2AL3MBTL1NPFFR1NPFFR2DRD2 | |
| SCHEMBL6169403 | 0.88 | KMT2A (0.49) | KMT2AL3MBTL1NPFFR1NPFFR2DRD2 | |
| SCHEMBL6484125 | 0.88 | KMT2A (0.49) | KMT2AL3MBTL1NPFFR1NPFFR2DRD2 | |
| SCHEMBL9245843 | 0.86 | KMT2A (0.51) | KMT2AL3MBTL1NPFFR1NPFFR2DRD2 | |
| SCHEMBL8775660 | 0.86 | KMT2A (0.51) | KMT2AL3MBTL1NPFFR1NPFFR2DRD2 | |
| SCHEMBL7835003 | 0.83 | KMT2A (0.55) | KMT2AL3MBTL1NPFFR1NPFFR2DRD2 | |
| SCHEMBL3187519 | 0.83 | KMT2A (0.55) | KMT2AL3MBTL1NPFFR1NPFFR2DRD2 | |
| SCHEMBL19121559 | 0.83 | KMT2A (0.55) | KMT2AL3MBTL1NPFFR1NPFFR2DRD2 | |
| SCHEMBL7834998 | 0.83 | KMT2A (0.55) | KMT2AL3MBTL1NPFFR1NPFFR2DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6900224-B2 | Antimicrobial quinolones, their compositions and uses | THE PROCTER & GAMBLE COMPANY (US) | 2005-05-31 | — | — | US | disclosed |
| EP-1532137-A2 | ANTIMICROBIAL AZA-BICYCLIC DERIVATES, THEIR COMPOSITIONS AND USES | THE PROCTER & GAMBLE COMPANY (US) | 2005-05-25 | — | — | EP | disclosed |
| US-20040038975-A1 | Antimicrobial quinolones, their compositions and uses | THE PROCTER & GAMBLE COMPANY | 2004-02-26 | — | — | US | disclosed |
| WO-2004014893-A2 | ANTIMICROBIAL AZA-BICYCLIC DERIVATES, THEIR COMPOSITIONS AND USES | THE PROCTER & GAMBLE COMPANY (US) | 2004-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040038975-A1 | Antimicrobial quinolones, their compositions and uses | QARS1, NQO2, Q6ZSR9 | KMT2A 4196/4885L3MBTL1 3861/4885NPFFR1 3546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.